Shopping Cart
Remove All
Your shopping cart is currently empty
LSD1-IN-43
Copy Product Info
😃Good
Catalog No. T210866
LSD1-IN-43 is a highly selective, reversible, and orally active LSD1 inhibitor with blood-brain barrier permeability, showing an IC50 value of 0.8 μM. It exhibits lower inhibitory activity against LSD1 homologs MAO-A and MAO-B. LSD1-IN-43 significantly inhibits Aβ aggregation and enhances neuronal cell viability induced by Aβ. It is applicable in Alzheimer's disease (AD) research.
LSD1-IN-43
LSD1-IN-43
Copy Product Info😃Good
Catalog No. T210866
LSD1-IN-43 is a highly selective, reversible, and orally active LSD1 inhibitor with blood-brain barrier permeability, showing an IC50 value of 0.8 μM. It exhibits lower inhibitory activity against LSD1 homologs MAO-A and MAO-B. LSD1-IN-43 significantly inhibits Aβ aggregation and enhances neuronal cell viability induced by Aβ. It is applicable in Alzheimer's disease (AD) research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | LSD1-IN-43 is a highly selective, reversible, and orally active LSD1 inhibitor with blood-brain barrier permeability, showing an IC50 value of 0.8 μM. It exhibits lower inhibitory activity against LSD1 homologs MAO-A and MAO-B. LSD1-IN-43 significantly inhibits Aβ aggregation and enhances neuronal cell viability induced by Aβ. It is applicable in Alzheimer's disease (AD) research. |
| In vitro | LSD1-IN-43 (10 μM) selectively and reversibly inhibits LSD1, with minimal impact on monoamine oxidase A (inhibition rate of 7%) and monoamine oxidase B (inhibition rate of 4.9%). At concentrations of 25-100 μM, LSD1-IN-43 demonstrates low toxicity and effectively reduces Aβ 1-42 production in HT22 cells. Additionally, at 10 μM, it significantly inhibits Aβ 1-42 aggregation with an inhibition rate of 66.19%, surpassing Curcumin's 49.98%. |
| In vivo | LSD1-IN-43 (125-500 μM, 24-56 h) exhibits a dose-dependent lifespan extension and decreases paralysis incidence in the CL4176 transgenic nematode model. Additionally, LSD1-IN-43 (40-80 mg/kg, i.g.) can restore levels of the histone marker (H3K9me2) regulated by LSD1, improving learning, memory, and cognitive function deficits in Alzheimer's disease mice. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy LSD1-IN-43 | purchase LSD1-IN-43 | LSD1-IN-43 cost | order LSD1-IN-43 | LSD1-IN-43 in vivo | LSD1-IN-43 in vitro
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.